Malignant Pediatric Soft Tissue & Bone Tumors of the Extremities: A Retrospective Study
NCT02557243 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 163
Last updated 2020-01-10
Summary
The aim of this study is to identify demographic \& disease characteristics in pediatric oncology patients diagnosed with soft tissue \& bone tumors involving the extremities \& treatment outcomes in these patients.
Conditions
- Soft Tissue Neoplasms
- Bone Neoplasms
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2019-11-30
- Completion
- 2019-12-31
Countries
- Egypt
Study Locations
More Related Trials
-
An Analysis of the Efficacy of High Dose Isofosfamide Through Elastomer
NCT04651569 ·Status: COMPLETED
-
Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children
NCT00552825 ·Status: COMPLETED
-
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors
NCT02536183 ·Status: TERMINATED ·Phase: PHASE1
-
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
NCT05120518 ·Status: RECRUITING
-
Dissecting Tumour MicroenvirOnment in Solid Paediatric Tumour to Improve Adoptive Cell Therapy
NCT07240207 ·Status: RECRUITING
-
Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models
NCT06822842 ·Status: NOT_YET_RECRUITING
-
PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma
NCT01585649 ·Status: COMPLETED ·Phase: PHASE1
-
Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia
NCT01688752 ·Status: WITHDRAWN
-
Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma
NCT00876031 ·Status: COMPLETED ·Phase: PHASE3
-
Oxaliplatin for Children With Solid Tumors
NCT01558453 ·Status: UNKNOWN ·Phase: PHASE2
-
Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors
NCT03245450 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study
NCT01565447 ·Status: COMPLETED
-
Paclitaxel/Ifosfamide/Cisplatin Chemotherapy for High Risk Pediatric Germ Cell Tumor
NCT05455918 ·Status: RECRUITING ·Phase: PHASE2
-
International PPB/DICER1 Registry
NCT03382158 ·Status: RECRUITING
-
Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma in Children
NCT07188311 ·Status: RECRUITING ·Phase: NA
-
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
NCT06156410 ·Status: RECRUITING ·Phase: PHASE1
-
Phase I Study of Safety and Feasibility of Transarterial Embolization of Incurable Hypervascular Pediatric Soft Tissue Sarcomas
NCT07136571 ·Status: WITHDRAWN ·Phase: NA
-
A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB
NCT01125800 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma
NCT03015844 ·Status: AVAILABLE
-
Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors
NCT00978146 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
NCT05634369 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
NCT02557854 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
NCT06235125 ·Status: RECRUITING ·Phase: PHASE1
-
Quality of Life in Children Cured of Retinoblastoma
NCT00278031 ·Status: UNKNOWN
-
A Prediction Model of Hematological Recovery After High-dose Chemotherapy in Pediatric Solid Tumor
NCT05024331 ·Status: COMPLETED